On the REPROCELL blog
Latest
OpenCRISPR-1: The First AI-Designed CRISPR Editor for High-Precision Gene & Cell Therapy
Discover OpenCRISPR-1 — the first fully AI-designed CRISPR–Cas editor. Built by generative large language model, it enables high-efficiency, high-specificity genome and base editing in human cells. Ideal for cell therapy, stem-cell research, and advanced gene-editing workflows.
16 December 2025
Enhancing Experimental Precision with the Alvetex® Advanced Culture System
Discover how Alvetex® Advanced enhances experimental precision with its flexible and functional 3D culture system for creating biologically accurate human skin models.
04 December 2025
iPSC-, MSC- and iMSC-Derived Exosome Therapeutics: The Cell-Free Future of Regenerative Medicine
Explore the future of regenerative medicine with iPSC-, MSC-, and iMSC-derived exosome therapeutics, focusing on their advantages, challenges, and clinical potential.
19 November 2025
Using Ex Vivo Skin Explants to Study Local Immune Responses in Psoriasis and Atopic Dermatitis
Explore the use of ex vivo skin explants to study local immune responses in chronic inflammatory skin diseases like psoriasis and atopic dermatitis.
17 November 2025